Jennifer Ann Cunningham, MD

Dr. Parekh is an Assistant Professor Medicine in the Division of Pulmonary, Allergy, and Critical Care. She received both her B.A. and M.D. degrees from Brown University in Providence, Rhode Island, as part of the 8-year Program in Liberal Medical Education (PLME). She completed her residency in Internal Medicine and fellowship in Pulmonary and Critical Care Medicine at Columbia University Irving Medical Center. Dr. Parekh is dedicated to providing excellent care to patients with pulmonary disease and critical care needs. She is a clinician educator and serves as the Medical Director of Critical Care Education in the Medical Intensive Care Unit. Her clinical expertise includes pulmonary diseases, critical care, respiratory failure, acute respiratory distress syndrome (ARDS), extracorporeal membrane oxygenation (ECMO) and critical care ultrasound.

Dr. John Salazar Schicchi is a distinguished physician specializing in Critical Care Medicine and Pulmonology, practicing in New York City. He serves as a Professor of Medicine at Columbia University and holds leadership roles including Section Chief of Pulmonary and Critical Care at NewYork-Presbyterian Allen Hospital and Director of the ICU there. Dr. Schicchi is board certified in critical care medicine, pulmonary disease, and sleep medicine, with a strong educational background that includes medical training from the University of Buenos Aires and fellowships at Bellevue Hospital Center and New York University Medical Center. He is committed to advancing patient care in critical pulmonary conditions and speaks Spanish, enhancing his ability to communicate with a diverse patient population. Generated from the website

Dr. Cummings is an Assistant Professor of Medicine in the Division of Pulmonary, Allergy, and Critical Care Medicine at Columbia University. His research interests lie at the intersection of infectious diseases and critical illness in sub-Saharan Africa, a low-income region where the global burden of severe infectious diseases is overwhelmingly concentrated. During the COVID-19 pandemic, Dr. Cummings' led the first prospective studies to characterize the clinical epidemiology of severe and critical COVID-19 in the U.S. and Uganda, and served as a co-investigator for international clinical trials of convalescent plasma and hyperimmune immunoglobulin in severe COVID-19.